**Aortic Valve Replacement for Calcified Aortic Valves**

Kazumasa Orihashi

[19] Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363(17):

[20] Kodali SK, O'Neill WW, Moses JW, et al. Early and late (one year) outcomes follow‐ ing transcatheter aortic valve implantation in patients with severe aortic stenosis

[21] Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generation of the CoreValve Revalv‐

[22] Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year

[23] Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am

[24] Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replace‐ ment for sévère aortic régurgitation in degenerated bioprosthesis : the first valve in valve procédure using Corevlave Revalving system. Catheter Cardiovasc Interv

[25] Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: step by

[26] Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve re‐ placement in selected high-risk patients with aortic stenosis. Circulation 2007 ;116(7):

(from the United States REVIVAL Trial). Am J Cardiol 2011;107(7): 1058-64.

ing system. Circ Cardiovasc Intervent 2008;1(3): 167-75.

Coll Cardiol 2011;57(16): 1650-7.

step. Ann Thorac Surg 2009;87(1): 276-83.

2007 ;70(5) :760-4.

755-63.

following CE mark approval. EuroIntervention 2008;4(2): 242-9.

1597-607.

498 Calcific Aortic Valve Disease

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/53418
